Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |